Chapter 33: Osteoporosis and Role of CrMS

Hilgers TW, 2004

Hilgers TW

The Medical and Surgical Practice of NaProTECHNOLOGY, 407-412, 2004

Abstract

No abstract available for this article.

Topics

Bone Health > Menstrual Cycle Effects > Ovulatory Disturbances Bone Health > Menstrual Cycle Effects > Amenorrhea Bone Health > Progesterone > Bone Formation Bone Health > Progesterone > Clinical Evidence Bone Health > Osteoporosis Risk > Premenopausal Bone Health > Osteoporosis Risk > Risk Factors Bone Health > Osteoporosis Risk > Prevention Diagnostics > Cycle Charting > Clinical Utility Diagnostics > Cycle Charting > Biomarker Correlation Diagnostics > Hormone Assays > Estrogen Diagnostics > Hormone Assays > Progesterone Diagnostics > Biomarker Monitoring > Cervical Mucus Menstrual Cycle > Biomarkers > Cervical Mucus Menstrual Cycle > Biomarkers > Hormonal Menstrual Cycle > Disorders > Amenorrhea Reproductive Endocrinology > Luteal Phase > Deficiency Reproductive Endocrinology > Estrogen > Physiology Reproductive Endocrinology > Estrogen > Clinical Effects Reproductive Endocrinology > Progesterone > Physiology Reproductive Endocrinology > Progesterone > Supplementation RRM Methods > NaProTECHNOLOGY > Clinical Outcomes Contraception/Comparison > Side Effects > Hormonal Contraception Contraception/Comparison > FABM vs Hormonal > Side Effects Perimenopause/Menopause > HRT > Benefits Perimenopause/Menopause > HRT > Alternatives Perimenopause/Menopause > Bone Health > Density Perimenopause/Menopause > Bone Health > Fracture Risk Perimenopause/Menopause > Bone Health > Prevention

Cite this article

Hilgers, T. W. (2004). Chapter 33: Osteoporosis and Role of CrMS. *The Medical and Surgical Practice of NaProTECHNOLOGY*, 407-412.

Keywords

Hormones; Biomarkers; Treatment; Reproductive Health; Osteoporosis Treatment; Bone Density Assessment; Hormonal Evaluation